午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook >> journal list >> Neurochemical Research >>article
Neurochemical Research

Neurochemical Research

IF: 3.7
Download PDF

A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies–Emphasis on Alzheimer’s Disease Pathogenesis

Published:5 February 2022 DOI: 10.1007/s11064-022-03530-2 PMID: 35122609
Mayuri Shukla, Prapimpun Wongchitrat, Piyarat Govitrapong

Abstract

Numerous challenges are confronted when it comes to the recognition of therapeutic agents for treating complex neurodegenerative diseases like Alzheimer’s disease (AD). The perplexing pathogenicity of AD embodies cholinergic dysfunction, amyloid beta (Aβ) aggregation, neurofibrillary tangle formation, neuroinflammation, mitochondrial disruption along with vicious production of reactive oxygen species (ROS) generating oxidative stress. In this frame of reference, drugs with multi target components could prove more advantageous to counter complex pathological mechanisms that are responsible for AD progression. For as much as, medicinal plant based pharmaco-therapies are emerging as potential candidates for AD treatment keeping the efficacy and safety parameters in terms of toxicity and side effects into consideration. Huperzine A (Hup A) is a purified alkaloid compound extracted from a club moss called Huperzia serrata. Several studies have reported both cholinergic and non-cholinergic effects of this compound on AD with significant neuroprotective properties. The present review convenes cumulative demonstrations of neuroprotection provided by Hup A in in vitro, in vivo, and human studies in various pathologies. The underlying molecular mechanisms of its actions have also been discussed. However, more profound evidence would certainly promote the therapeutic implementation of this drug thus furnishing decisive insights into AD therapeutics and various other pathologies along with preventive and curative management.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Huperzine A 120786-18-7 C15H18N2O 202 suppliers $62.00-$1200.00
(-)-HUPERZINE A C15H18N2O 12 suppliers Inquiry

Similar articles

IF:4.4

Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease

Frontiers in Pharmacology S. Beggiato,?M. C. Tomasini,etc Published: 24 July 2019
IF:0

Therapeutic Potential of Isoflavones with an Emphasis on Daidzein.

Oxidative Medicine and Cellular Longevity Mohammed M Alshehri,?Javad Sharifi-Rad,etc Published: 9 September 2021
IF:5.4

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease.

ACS Applied Energy Materials María Jesús Friedli, Nibaldo C Inestrosa,etc Published: 29 October 2021